08048035996
Revolade 25 mg Good Quality Tablets to UK - Birmingham | Phoenix Exim | Trusted Exporter

1. General Information

Revolade 25 mg is an oral tablet containing 25 mg of eltrombopag (as eltrombopag olamine). It belongs to the class of medicines known as thrombopoietin receptor agonists. It is primarily used for conditions associated with low platelet counts, including certain cases of immune thrombocytopenia (ITP).

2. Product Information

  • Brand: Revolade
  • Strength: 25 mg
  • Active ingredient: Eltrombopag
  • Dosage form: Film-coated tablet
  • Route: Oral
  • Therapeutic class: Thrombopoietin receptor agonist
  • Prescription status: Prescription-only medicine
  • Manufacturer/brand holder: Novartis
  • Appearance: White, round, biconvex film-coated tablet; the UK product information describes the 25 mg tablet as marked with “GS NX3” and “25.”

3. Uses of Revolade 25 mg

Revolade may be prescribed for:

  • Primary immune thrombocytopenia (ITP) when previous treatments such as corticosteroids or immunoglobulins have not provided an adequate response.
  • Thrombocytopenia associated with chronic hepatitis C in specific treatment settings.
  • Acquired severe aplastic anaemia (SAA) in appropriate adult patients when specified treatment criteria are met.

The exact indication and suitability depend on the patient's condition, age, platelet count, liver function and previous treatment.

4. Benefits of Revolade 25 mg

Potential clinical benefits include:

  • Helps increase platelet production.
  • Can improve platelet counts in patients with certain forms of thrombocytopenia.
  • May reduce the risk of bleeding associated with very low platelet counts.
  • Can provide an alternative treatment option when other therapies for ITP have not worked adequately.
  • In appropriately selected patients, increased platelet counts may help enable or maintain treatment for certain underlying conditions.

Important: The goal is generally to achieve an appropriate platelet level rather than to normalize the platelet count unnecessarily.

5. Side Effects of Revolade 25 mg

Possible adverse effects include:

  • Headache
  • Nausea
  • Diarrhoea
  • Increased liver enzymes
  • Fatigue
  • Muscle pain
  • Rash
  • Abdominal discomfort

More serious risks can include liver injury and blood clots (thromboembolic events). Appropriate laboratory and clinical monitoring is therefore important during treatment.

6. Common Side Effects

Some commonly reported effects may include:

  • Headache
  • Nausea
  • Diarrhoea
  • Dry mouth
  • Abdominal pain
  • Fatigue
  • Muscle aches
  • Increased liver enzyme levels

Patients should inform their healthcare professional if side effects are persistent, severe or unusual.

7. How to Use Revolade 25 mg

Revolade should be taken exactly according to the prescribing doctor's instructions. The dose can vary depending on the indication, platelet response, age, ethnicity and liver function, and may be adjusted during treatment.

Important administration considerations include:

  • Take the tablet orally as prescribed.
  • Do not change the dose yourself.
  • Revolade has important interactions with calcium-rich foods and products containing polyvalent cations, so timing in relation to food, antacids or mineral supplements should follow the product instructions.
  • Regular platelet and liver-function monitoring may be required.
  • Do not stop treatment without consulting your doctor.

8. How Revolade 25 mg Works

Eltrombopag works by stimulating the thrombopoietin (TPO) receptor. TPO normally stimulates cells in the bone marrow involved in platelet production. By activating this receptor, eltrombopag promotes platelet production and can increase the number of circulating platelets.

9. Safety Advice

  • Use Revolade only under medical supervision.
  • Regular blood-count and liver-function monitoring may be required.
  • Tell your doctor if you have liver disease or a history/risk of blood clots.
  • Seek urgent medical attention for symptoms suggestive of a blood clot, such as sudden chest pain, difficulty breathing, severe abdominal pain or swelling/pain in a limb.
  • Report symptoms of liver injury, including yellowing of the skin or eyes, dark urine or unusual worsening fatigue.
  • Do not take more than the prescribed dose.
  • Keep the medicine out of reach of children.
  • Inform your doctor about all prescription medicines, supplements and mineral-containing products you take.
  • Pregnancy and breastfeeding require individual medical advice.

Because eltrombopag can affect liver function and platelet levels, appropriate monitoring is an important part of safe treatment.

10. Frequently Asked Questions

Q1. What is Revolade 25 mg used for?
Revolade 25 mg is used for certain conditions involving low platelet counts, particularly ITP, and in specific patients with chronic hepatitis C-associated thrombocytopenia or acquired severe aplastic anaemia.

Q2. What is the active ingredient in Revolade?
The active ingredient is eltrombopag, supplied as eltrombopag olamine.

Q3. Is Revolade 25 mg a prescription medicine?
Yes. It is a prescription-only medicine and treatment should be supervised by an appropriate healthcare professional.

Q4. Does Revolade increase platelet count?
Yes. Eltrombopag stimulates thrombopoietin receptors and promotes platelet production in the bone marrow.

Q5. Can I take Revolade with food?
Food can affect eltrombopag absorption, particularly food containing calcium. Follow the specific administration instructions provided by your doctor and the product leaflet.

Q6. Can Revolade be used without monitoring?
No. Platelet counts and, where appropriate, liver function should be monitored during treatment.

Q7. Can I stop Revolade suddenly?
Do not stop it without medical advice. Your doctor should determine whether treatment should be continued, adjusted or discontinued.

Q8. Is Revolade suitable for everyone with low platelets?
No. The cause of thrombocytopenia must be established, and treatment suitability is determined by a healthcare professional.

11. Substitutes for Revolade 25 mg

Possible alternatives containing eltrombopag may be available under different brand or generic names in different countries. For example, Eltrombopag tablets from other manufacturers may contain the same active ingredient. The EMA identifies Eltrombopag Accord as a medicine whose reference medicine is Revolade.

A substitute should not be selected based solely on the same strength. The prescriber or pharmacist should confirm the active ingredient, formulation, indication, strength and regulatory availability before substitution.

12. SEO Keywords

  • Revolade 25 mg Tablet exporter from India
  • Revolade 25 mg Tablet supplier from Nagpur
  • Revolade 25 mg Eltrombopag exporter
  • Revolade 25 mg tablets wholesale supplier
  • Buy Revolade 25 mg tablets from India
  • Revolade 25 mg international medicine supplier
  • Eltrombopag 25 mg tablet exporter India
  • Eltrombopag 25 mg pharmaceutical supplier
  • Revolade 25 mg medicine exporter to USA
  • Revolade 25 mg medicine exporter to UK
  • Revolade 25 mg supplier to Australia
  • Revolade 25 mg supplier to Singapore
  • Revolade 25 mg exporter to Canada
  • Revolade 25 mg supplier to South Korea
  • Revolade 25 mg exporter to UAE
  • ITP medicine supplier from India
  • Eltrombopag tablets wholesale exporter
  • Thrombocytopenia medicine exporter India
  • Eltrombopag 25 mg international supplier
  • Revolade 25 mg pharmaceutical exporter Nagpur
  • Prescription medicine exporter from India
  • Indian pharmaceutical exporter for international markets
  • Trusted medicine exporter from Nagpur India
  • Revolade 25 mg B2B pharmaceutical supplier
  • Eltrombopag 25 mg B2B exporter India
Aug 14th, 2026 1:58 PM

Keywords